Information  X 
Enter a valid email address

Company Name matching 'DBV Technologies S.A'

Date
Time Source
Company
Announcement
15 Sep 2020 9:30 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and  total number of shares of the Company as of August 31, 2020
09 Sep 2020 6:30 am GNW   DBV Technologies S.A. DBV Technologies Announces Leadership Changes
02 Sep 2020 9:30 pm GNW   DBV Technologies S.A. DBV Technologies to Participate in Multiple September Investor Conferences
12 Aug 2020 9:01 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2020
04 Aug 2020 6:30 am GNW   DBV Technologies S.A. DBV Technologies Receives Complete Response Letter from FDA for Viaskin Peanut BLA in Children Ages 4-11 Years
31 Jul 2020 6:30 am GNW   DBV Technologies S.A. DBV Technologies Reports First Half 2020 Financial Results
20 Jul 2020 9:01 pm GNW   DBV Technologies S.A. Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
15 Jul 2020 9:01 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2020
10 Jul 2020 2:00 pm GNW   DBV Technologies S.A. DBV Technologies Announces Publication of PEOPLE Phase III Open-Label Extension Study Evaluating Viaskin Peanut in The Journal of Allergy and Clinical Immunology
26 Jun 2020 7:30 am GNW   DBV Technologies S.A. DBV Technologies Provides Operational and Business Update
11 Jun 2020 9:01 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2020
04 Jun 2020 9:30 pm GNW   DBV Technologies S.A. DBV Technologies to Present Data on Epicutaneous Immunotherapy and Food Allergy Quality of Life at EAACI Digital Congress 2020
02 Jun 2020 9:30 pm GNW   DBV Technologies S.A. DBV Technologies To Present at the Goldman Sachs 41st Annual Global Healthcare Conference
12 May 2020 9:01 pm GNW   DBV Technologies S.A. Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2020
30 Apr 2020 9:01 pm GNW   DBV Technologies S.A. DBV Technologies Reports March 31, 2020 Cash Position
20 Apr 2020 9:01 pm GNW   DBV Technologies S.A. DBV Technologies Announces Results of its 2020 Ordinary and Extraordinary General Meeting
15 Apr 2020 11:00 am GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company
10 Apr 2020 9:01 pm GNW   DBV Technologies S.A. Ordinary and Extraordinary General Meeting of April 20, 2020 to be Held in Closed Virtual Session Due to COVID-19 Pandemic
30 Mar 2020 9:01 pm GNW   DBV Technologies S.A. Ordinary and Extraordinary General Meeting of April 20, 2020
26 Mar 2020 3:00 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company
20 Mar 2020 8:15 pm GNW   DBV Technologies S.A. DBV Technologies Announces Filing of 2019 Universal Registration Document and 2019 Annual Report on Form 20-F
17 Mar 2020 8:00 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and  total number of shares of the Company as of February 29, 2020 and March 4, 2020
16 Mar 2020 8:30 pm GNW   DBV Technologies S.A. DBV Technologies Provides Update on Viaskin Peanut BLA for Children Ages 4-11 Years
04 Mar 2020 9:30 pm GNW   DBV Technologies S.A. DBV Technologies Reports Full-Year 2019 Financial Results and Provides Business Update
  9:01 pm GNW   DBV Technologies S.A. DBV Technologies Announces Closing of Underwriters’ Option to Purchase Additional Ordinary Shares in the Form of American Depositary Shares in Connection With its Global Offering
02 Mar 2020 6:30 am GNW   DBV Technologies S.A. DBV Technologies Announces Partial Exercise of Underwriters’ Option to Purchase Additional Shares in Connection With its Global Offering of Ordinary Shares in the Form of American Depositary Shares (ADSs)
24 Feb 2020 9:00 pm GNW   DBV Technologies S.A. DBV Technologies to Present Detailed Safety and Efficacy Data of Viaskin Peanut at AAAAI 2020
21 Feb 2020 2:29 pm GNW   DBV Technologies S.A. DBV Technologies Announces FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment of Peanut Allergy in Children
10 Feb 2020 9:00 pm GNW   DBV Technologies S.A. DBV Technologies to Present at the SVB Leerink 9th Annual Global Healthcare Conference
07 Feb 2020 1:00 am GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2020 and February 4, 2020
06 Feb 2020 9:01 pm GNW   DBV Technologies S.A. DBV Technologies Announces Appointment of Pascal Wotling as Chief Technical Operations Officer
04 Feb 2020 9:30 pm GNW   DBV Technologies S.A. DBV Technologies Announces Closing of Global Offering
30 Jan 2020 6:30 am GNW   DBV Technologies S.A. DBV Technologies Announces Pricing of $153.7 million (€139.8 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares
29 Jan 2020 9:05 pm GNW   DBV Technologies S.A. DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares, and Reports December 31, 2019 Cash Position
15 Jan 2020 9:00 pm GNW   DBV Technologies S.A. Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
14 Jan 2020 9:00 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company
08 Jan 2020 9:30 pm GNW   DBV Technologies S.A. DBV Technologies Reports Positive Three-Year, Long-Term Data from the PEOPLE Phase III Open-Label Extension Study of Viaskin Peanut in Children with Peanut Allergy
02 Jan 2020 9:30 pm GNW   DBV Technologies S.A. DBV Technologies Announces Appointment of Ramzi Benamar as Chief Financial Officer
10 Dec 2019 9:00 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and  total number of shares of the Company
19 Nov 2019 9:00 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company
05 Nov 2019 9:30 pm GNW   DBV Technologies S.A. DBV Technologies to Present at the Stifel 2019 Healthcare Conference
24 Oct 2019 9:01 pm GNW   DBV Technologies S.A. DBV Technologies to Highlight the Burden of Peanut Allergy and Patient Experiences with Viaskin Peanut at ACAAI 2019
16 Oct 2019 11:30 am GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company
15 Oct 2019 9:30 pm GNW   DBV Technologies S.A. DBV Technologies Announces Closing of Global Offering
10 Oct 2019 6:30 am GNW   DBV Technologies S.A. DBV Technologies Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Connection With its Global Offering of Ordinary Shares in the Form of American Depositary Shares (ADSs)
09 Oct 2019 6:30 am GNW   DBV Technologies S.A. DBV Technologies Announces Pricing of $125 million (€114 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares
08 Oct 2019 9:18 pm GNW   DBV Technologies S.A. DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares, and Reports September 30, 2019 Cash Position
04 Oct 2019 4:45 pm GNW   DBV Technologies S.A. DBV Technologies Announces FDA Acceptance of BLA filing for Viaskin Peanut for the Treatment of Peanut Allergy
02 Oct 2019 9:00 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company
19 Sep 2019 9:00 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company
07 Aug 2019 9:05 pm GNW   DBV Technologies S.A. DBV Technologies Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin Peanut for the Treatment of Peanut Allergy
01 Aug 2019 6:30 am GNW   DBV Technologies S.A. DBV Technologies Reports First Half 2019 Financial Results
18 Jul 2019 6:30 am GNW   DBV Technologies S.A. Amendment to the DBV Technologies Liquidity Contract with NATIXIS ODDO BHF and Half-Year Report
12 Jul 2019 11:00 am GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company
26 Jun 2019 6:30 am GNW   DBV Technologies S.A. DBV Technologies Announces Appointment of Pharis Mohideen, M.D., as Chief Medical Officer  
11 Jun 2019 1:00 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company
03 Jun 2019 6:30 am GNW   DBV Technologies S.A. DBV Technologies to Attend Upcoming Investor Conferences
01 Jun 2019 1:00 pm GNW   DBV Technologies S.A. DBV Technologies to Present Data from Epicutaneous Immunotherapy at EAACI 2019
24 May 2019 9:30 pm GNW   DBV Technologies S.A. DBV Technologies Announces Results of its 2019 Ordinary and Extraordinary General Meeting and the Appointment of Viviane Monges to the Board of Directors
14 May 2019 6:30 am GNW   DBV Technologies S.A. DBV Technologies Announces Departure of Deputy CEO David Schilansky


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t